ATX-201

N/A

Report date: 2026/03/31 20:00:21
NME

Base Information

Drug NameATX-201
Drug Alias NameATX-201ATx201
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin inhibitors
TargetsTubulin
Therapy Area/IndicationsDermatitis, ContactDermatitis, AtopicImpetigo +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBulgariaCanadaUnited States +[7
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUnion Therapeutics A/S
Active IndicationsN/A
Inactive IndicationsDermatitis, ContactDermatitis, AtopicImpetigo +[4

Other Information

ATC CodeN/A
Related LinksDrugBank